.
Browse the new website of HIT
Vision:
To make HIT the main and integrated Research Pole in the fields of Transport, Sustainable Mobility and Tourism in Greece and among the top 10 relevant nodes of technology and expertise in Europe.

Title of Service

 Clinical Trials: Medicines & Driving task

Who are our clients?

Indicative interested parties are the following:

  • Drug companies
  • Research institutes and centres carrying out research that have no or limited ‘know-how’ and/ or technical infrastructure
  • Organizations and public bodies/ centres

Goals

The overarching goal is to reduce Driving Under the Influence of Medicines (DUIM) accidents through the following activities:

  • Inform healthcare professionals about the effects of medicines on driving performance;
  • Effect on driving performance of patients under medication;
  • Efficient and effective dissemination of results from studies conducted in collaboration with pharmaceutical companies;
  • Increasing the reliability and enhancing the social profile of pharmaceutical companies.

Description

CERTH/ HIT has the capacity and experience to talk up the complete and entire process of investigating the effect of medicines on driving ability and behaviour or partially support specific aspects of the research/ study, such as the following:

  • Study design
  • Research protocol submission/Approval by National Medicine Organization (EOF)
  • Conduction, management and monitoring of simulated driving experience experiments
  • Data management
  • Statistical analyses
  • Reporting
  • Contact with regulatory authorities
  • Quality assurance
  • Public dissemination

outsource 

Figure 1. Holistic service provision

Cost

Testing in simulated environment (for a two-month study) requires half the duration and cost from conducting the experiments on the road (€175 000) (MEDSCAPE, 2013). Indicative cost estimation for the whole study is € 79,950 and it can be translated into a saving of 46%-123%. The team is experienced in applying the Tiered approach (NHTSA & FDA, 2011) and can efficiently support international studies apart from national research efforts. Definite cost estimation is possible only after consultation with the research team.

Contact

Katerina Touliou
Research associate
6th km Charilaou-Thermis
57001
Thermi
Thessaloniki
Tel: +302310 - 498488, email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Δεσμός για W3C HTML5 validator
Δεσμός για AChecker Web Accessibility Checker
Copyright ® 2017, HH, All rights reserved.